Royalty Pharma PLC (RPRX)
25.80
+0.10
(+0.37%)
USD |
NASDAQ |
Nov 18, 16:00
25.80
0.00 (0.00%)
After-Hours: 19:35
Royalty Pharma Market Cap: 11.46B for Nov. 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 15, 2024 | 11.42B |
| November 14, 2024 | 11.37B |
| November 13, 2024 | 11.49B |
| November 12, 2024 | 11.55B |
| November 11, 2024 | 11.71B |
| November 08, 2024 | 11.65B |
| November 07, 2024 | 11.78B |
| November 06, 2024 | 11.84B |
| November 05, 2024 | 12.24B |
| November 04, 2024 | 12.09B |
| November 01, 2024 | 12.04B |
| October 31, 2024 | 12.04B |
| October 30, 2024 | 12.13B |
| October 29, 2024 | 12.11B |
| October 28, 2024 | 12.16B |
| October 25, 2024 | 12.02B |
| October 24, 2024 | 12.17B |
| October 23, 2024 | 12.20B |
| October 22, 2024 | 12.21B |
| October 21, 2024 | 12.38B |
| October 18, 2024 | 12.48B |
| October 17, 2024 | 12.51B |
| October 16, 2024 | 12.59B |
| October 15, 2024 | 12.42B |
| October 14, 2024 | 12.43B |
| Date | Value |
|---|---|
| October 11, 2024 | 12.50B |
| October 10, 2024 | 12.26B |
| October 09, 2024 | 12.30B |
| October 08, 2024 | 12.20B |
| October 07, 2024 | 12.30B |
| October 04, 2024 | 12.38B |
| October 03, 2024 | 12.38B |
| October 02, 2024 | 12.60B |
| October 01, 2024 | 12.66B |
| September 30, 2024 | 12.62B |
| September 27, 2024 | 12.64B |
| September 26, 2024 | 12.63B |
| September 25, 2024 | 12.39B |
| September 24, 2024 | 12.42B |
| September 23, 2024 | 12.42B |
| September 20, 2024 | 12.34B |
| September 19, 2024 | 12.54B |
| September 18, 2024 | 12.64B |
| September 17, 2024 | 12.66B |
| September 16, 2024 | 12.66B |
| September 13, 2024 | 12.42B |
| September 12, 2024 | 12.35B |
| September 11, 2024 | 12.45B |
| September 10, 2024 | 12.57B |
| September 09, 2024 | 12.60B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
11.37B
Minimum
Nov 14 2024
20.50B
Maximum
Jan 26 2021
15.64B
Average
16.18B
Median
Apr 21 2023
Market Cap Benchmarks
| Geron Corp | 2.276B |
| Amicus Therapeutics Inc | 2.888B |
| Ionis Pharmaceuticals Inc | 5.327B |
| Arbutus Biopharma Corp | 668.91M |
| Syndax Pharmaceuticals Inc | 1.374B |
Market Cap Related Metrics
| PE Ratio | 10.12 |
| PS Ratio | 6.786 |
| Price to Book Value | 1.668 |
| Price to Free Cash Flow | 5.494 |
| Price | 25.80 |
| Earnings Yield | 9.89% |
| Operating PE Ratio | 9.961 |
| Normalized PE Ratio | 13.16 |